Moreover, we found ALS-BCMA could be an early, and easily assessable biomarker for memory B cell induction, as well be a useful biomarker to reflect the overall oral adjuvanticity of dmLT. Here, TNFRSF17 is linked to amyotrophic lateral sclerosis.